157 E 32nd St. New York, NY 10016 212-689-6791
Array
(
    [0] => 2773
    [1] => 2772
    [2] => 2771
    [3] => 2770
)

FDA Approves Opdivo-Yervoy Combo for Unresectable or Metastatic Melanoma
Cancer Network
October, 2015
http://www.cancernetwork.com/skin-cancer-melanoma-targets/fda-approves-opdivo-yervoy-combo-unresectable-or-metastatic-melanoma

FDA Approves Ipilimumab for Earlier Stage Melanoma
Ipilimumab (Yervoy) is now approved by the Food and Drug Administration as an adjuvant therapy for stage III melanoma patients.

Cancer Network
October, 2015
http://www.cancernetwork.com/skin-cancer-melanoma-targets/fda-approves-ipilimumab-earlier-stage-melanoma

FDA Approves First Oncolytic Virus With New Melanoma Therapy
Cancer Network
October, 2015
http://www.cancernetwork.com/melanoma/fda-approves-first-oncolytic-virus-new-melanoma-therapy

Vermont physicians treat melanoma with new drugs WCAX
July 31, 2014
http://www.wcax.com/story/26164670/fahc-doctors-treat-melanoma-patients-with-new-drugs

Pembrolizumab Works in Melanoma After Ipilimumab Medscape
July 23, 2014
http://www.medscape.com/viewarticle/828738

Roche’s Melanoma Skin-Cancer Drug Study Meets Goals
The Wall Street Journal July 14, 2014
http://online.wsj.com/articles/roches-melanoma-skin-cancer-drug-study-meets-goals-1405317979

Immunotherapy Advances in Melanoma
OncLive
July 28, 2014
http://www.onclive.com/publications/obtn/2014/July-2014/Immunotherapy-Advances-in-Melanoma

Role of Adjuvant Radiation Therapy in Melanoma
OncLive
July 25, 2014
http://www.onclive.com/peer-exchange/metastatic-melanoma/Role-of-Adjuvant-Radiation-Therapy-in-Melanoma